Lung Cancer

1

Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer

Lee, Ha Yeon, Ahn, Hee Kyung, Jeong, Ji Yun, Kwon, Mi Jung, Han, Jung-Ho, Sun, Jong-Mu, Ahn, Jin Seok, Park, Keunchil, Choi, Yoon-La, Ahn, Myung-Ju

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 533 KB

english, 2013

2

Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose

Li, Hang, Pan, Yunjian, Li, Yuan, Li, Chenguang, Wang, Rui, Hu, Haichuan, Zhang, Yang, Ye, Ting, Wang, Lei, Shen, Lei, Sun, Yihua, Chen, Haiquan

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 275 KB

english, 2013

3

Editorial Board

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 57 KB

english, 2013

4

Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: Case report and literature review

Prat, Lola, Chouaid, Christos, Kettaneh, Adrien, Fardet, Laurence

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 671 KB

english, 2013

6

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

Bertino, Erin M., Bekaii-Saab, Tanios, Fernandez, Soledad, Diasio, Robert B., Karim, Nagla A., Otterson, Gregory A., Villalona-Calero, Miguel A.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 252 KB

english, 2013

7

Treatment of depression in people with lung cancer: A systematic review

Walker, Jane, Sawhney, Aarti, Hansen, Christian Holm, Symeonides, Stefan, Martin, Paul, Murray, Gordon, Sharpe, Michael

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 256 KB

english, 2013

8

Clinical factors predictive of long-term survival in advanced non-small cell lung cancer

Van Damme, V., Govaerts, E., Nackaerts, K., Dooms, C., Wauters, I., Vansteenkiste, J.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 262 KB

english, 2013

9

Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer

Yang, Jin-Ji, Chen, Hua-Jun, Yan, Hong-Hong, Zhang, Xu-Chao, Zhou, Qing, Su, Jian, Wang, Zhen, Xu, Chong-Rui, Huang, Yi-Sheng, Wang, Bin-Chao, Yang, Xue-Ning, Zhong, Wen-Zhao, Nie, Qiang, Liao, Ri-Qia

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 700 KB

english, 2013

10

Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?

Ochi, Nobuaki, Yamane, Hiromichi, Yamagishi, Tomoko, Takigawa, Nagio, Monobe, Yasumasa

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 869 KB

english, 2013

11

Psf3 is a prognostic biomarker in lung adenocarcinoma

Hokka, Daisuke, Maniwa, Yoshimasa, Tane, Shinya, Nishio, Wataru, Yoshimura, Masahiro, Okita, Yutaka, Ohbayashi, Chiho, Sakai, Yasuhiro, Chen, Xue, Hayashi, Yoshitake

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 589 KB

english, 2013

12

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

Baird, Anne-Marie, Leonard, Jennifer, Naicker, Krisha M., Kilmartin, Lisa, O’Byrne, Kenneth J., Gray, Steven G.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 816 KB

english, 2013

13

The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer

Sas-Korczynska, Beata, Sokolowski, Andrzej, Korzeniowski, Stanislaw

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 376 KB

english, 2013

14

The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients

Xu, Xiaojing, Han, Lifang, Yang, Huaping, Duan, Li, Zhou, Boting, Zhao, Yingchun, Qu, Jian, Ma, Rui, Zhou, Honghao, Liu, Zhaoqian

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 393 KB

english, 2013

15

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: Pooled analysis of SAKK19/05 and NTR528

Gautschi, Oliver, Dingemans, Anne-Marie, Crowe, Susanne, Peters, Solange, Roder, Heinrich, Grigorieva, Julia, Roder, Joanna, Zappa, Francesco, Pless, Miklos, Brutsche, Martin, Baty, Florent, Bubendorf

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 283 KB

english, 2013

16

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

Hotta, Katsuyuki, Suzuki, Etsuji, Di Maio, Massimo, Chiodini, Paolo, Fujiwara, Yoshiro, Takigawa, Nagio, Ichihara, Eiki, Reck, Martin, Manegold, Christian, Pilz, Lothar, Hisamoto-Sato, Akiko, Tabata,

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 475 KB

english, 2013

17

Clinical impact of ki-67 labeling index in non-small cell lung cancer

Jakobsen, Jan Nyrop, Sørensen, Jens Benn

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 258 KB

english, 2013

18

Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft–Gault with different weight descriptors

Kaag, Dieter

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 198 KB

english, 2013

19

Human papillomaviruses (HPVs) in lung cancer: A causative trigger or just a co-incidence?

Sourvinos, George, Mammas, Ioannis N., Derdas, Stavros, Spandidos, Demetrios A.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 488 KB

english, 2013

20

Acknowledgement to Reviewers 2011

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 123 KB

english, 2013

Volume 79; Issue 1

Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer

Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose

Editorial Board

Contents

Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: Case report and literature review

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

Treatment of depression in people with lung cancer: A systematic review

Clinical factors predictive of long-term survival in advanced non-small cell lung cancer

Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer

Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?

Psf3 is a prognostic biomarker in lung adenocarcinoma

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer

The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: Pooled analysis of SAKK19/05 and NTR528

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

Clinical impact of ki-67 labeling index in non-small cell lung cancer

Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft–Gault with different weight descriptors

Human papillomaviruses (HPVs) in lung cancer: A causative trigger or just a co-incidence?

Acknowledgement to Reviewers 2011